We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » US, EU and Japan Announce Progress on Syncing Antibacterials Research
US, EU and Japan Announce Progress on Syncing Antibacterials Research
The FDA, EMA and Japan’s Pharmaceuticals and Medical Devices Agency have made strides toward aligning clinical trial designs for antibacterial drug indications, the regulators announced following their fourth tripartite meeting in Tokyo.